Introduction:
Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive artificial airway (endotracheal tube or tracheostomy tube). The use of noninvasive ventilation has markedly increased over the past two decades as it has been proved to be aan efficient method for selective conditions and by which invasive mechanical ventilation can be avoided along with its complications. NIV has already proven to have beneficial effects like reducing complications (like VAP, ventilator dependency), reducing hospital stay and cost. Noninvasive ventilation has now become an integral tool in the management of both acute and chronic respiratory failure, in both the home setting and in the critical care unit. Noninvasive ventilation has been used as a replacement for invasive ventilation, but its flexibility also allows it to be a valuable complement in patient management.
At the ICU concerned our team is doing an observational study to draw do periodic assessment & to draw some conclusions to generate some specific recommendations from the observations regarding NIV.
Methods of delivery:
Delivering positive airway pressure through a mask (which is primarily discussed in this text) has become the predominant method of providing noninvasive ventilatory support. It reduces respiratory rate, increase in tidal volume, decrease in dyspnea by reducing transdiaphragmatic pressures, work of breathing and improvement in oxygenation with a reduction in hypercapnia.
Ventilatory support can bewas delivered through a variety of interfaces (mouth piece, nasal msak, full-face mask, or helmet mask), using a variety of ventilatory modes (eg, volume ventilation, pressure support, bi-level positive airway pressure proportional-assist ventilation, continuous positive airway pressure etc.) with either ventilators dedicated to noninvasive ventilation (NIV) or those capable of providing support through an endotracheal tube or mask.
Negative-pressure ventilators provide ventilatory support using a device that encases the thoracic cage starting Bangladesh Crit Care J March 2013; 1: 3-7 from the neck, and devices range from a whole-body tank to a cuirass shell. The general principal is the same with a vacuum device, which lowers the pressure surrounding the thorax, creating subatmospheric pressure and thereby passively expanding the chest wall with diaphragmatic descent, all leading to lung inflation. Exhalation occurs with passive recoil of the chest wall (which is not discussed here).
Patient interfaces:
In its simplest terms, noninvasive ventilation differs from invasive ventilation by the interface between the patient and the ventilator. Invasive ventilatory support is provided via either an endotracheal tube or tracheostomy tube. Noninvasive ventilatory support uses a variety of interfaces, and these have continued to evolve with modifications based on patient comfort and efficacy.
Nasal masks and orofacial masks were the earliest interfaces, with subsequent development and use of full face masks, mouthpieces, nasal pillows, and helmets. Nasal masks and orofacial masks are still the most commonly used interfaces. Orofacial masks are used almost twice as frequently as nasal masks. Both have advantages and disadvantages in the application of noninvasive ventilation.
Proper fitting of the mask or other interface is one of theanother key component to successful noninvasive ventilation. The mask or interface may be held in place (without straps applied) by the patient or therapist to familiarize the patient with the mask and ventilator. Typically, the smallest mask providing a proper fit is the most effective. Straps hold the mask in place, with care to minimize excess pressure on the face or nose. Leaks are the bane of all of the interfaces, but excess pressure applied with the straps increases the risk of pressure necrosis and skin breakdown. Straps should be tight enough to prevent leaks, but with enough slack to allow passage of 1 or 2 fingers between the face and the straps.
While orofacial masks and nasal masks are the most commonly used interfaces, other patient ventilator interfaces through which noninvasive ventilation can be applied include mouthpieces, nasal pillows, total face masks, and even a helmet device, which encompasses the entire head.
In patients with a higher severity of illness, the orofacial mask and total face mask appear to result in comparable outcomes.
Orofacial masks (general advantages)
• Best suited for less cooperative patients
• Better in patients with a higher severity of illness
• Better for patients with mouth-breathing or pursedlips breathing
• Better in edentulous patients
• Generally more effective ventilation
Orofacial masks (cautions, disadvantages)
• Claustrophobic
• Hinder speaking and coughing
• Risk of aspiration with emesis

Nasal masks (general advantages)
• Best suited for more cooperative patients
• Better in patients with a lower severity of illness
• Not claustrophobic
• Allows speaking, drinking, coughing, and secretion clearance
• Less aspiration risk with emesis
• Generally better tolerated
Nasal masks (cautions, disadvantages)
• More leaks possible (eg, mouth-breathing or edentulous patients)
• Effectiveness limited in patients with nasal deformities or blocked nasal passages
Ventilators:
Early noninvasive ventilatory support was applied using either large bedside critical care volume ventilators or smaller volume or pressure specialty ventilators devoted to noninvasive ventilation. While the critical care ventilators had more options, they were also less tolerant of leaks. The specialty ventilators hMany critical care ventilators currently in use also have a noninvasive ventilation option, either as part of the original device or available as an upgrade option. The ideal device is dependent on a number of factors, including familiarity by staff and available options. The differences between the bedside critical care ventilator and specialty noninvasive ventilator continue to diminish as differences related to ventilator options, range of support, and leak tolerance are corrected in both devicesad fewer options and range, but they were more leak tolerant. All of our patients who got NIV support in our ICU was given support by BiPAP mode. 
Modes of ventilation
Predictors of successful noninvasive ventilation
Patient inclusion criteria:
Clinical parameters:
• Better out come
• CKD with pulmonary oedema: The outcome was good, 12 out of 16 patients, ended with positive outcome (75%). As thsesthese pts main cause of respiratory distress wereis due to fluid overload whicsh was corrected in a very short time by haemo dialysis & pt no longer needed ett endotracheal intubation.
• Acute exacerbation of COPD: It was 100% successful (6 out of 6). And it was applied to wide range of PH & PCO 2 variations.
• Acute LVF: Acute cardiogenicCardiogenic pulmonary oedema has over all success rate15 out of 21(71.42%), but those pts having ough has ongoing ischemia (relative contraindication) hadhas increased failure rate (only 2 succeded out of 6). But those pts who diddoes not have active ischemia hadas a better outcome (13 out of 15).
• Acute exacerbation of Bronchial Asthma: Our 1 st pt had Br asthma & it was a successful case but our over all success rate is 50% (2 out of 4).
• Post Extubation: So far our success rate was 100% (3 out of 3).
• ALI due to acute pancreatitis: Had 100% success rate (n=2).
Poor out come · Community Acquired Pneumonia: Its out come was poor (1 out of 16) irrespective of clinical of ABG parameter.
• Sepsis with MOF: It had 100% failure rate (n=4).
• Acute Abdomen (PGCHV, Intestinal obstruction, Ca pancreas): Had 0% success rate.
• Bronchogenic Ca: Had 0% success rate.
Discussion:
Noninvasive Ventilation in COPD
The largest review concluded that noninvasive ventilation decreased the intubation rate by 28% (95% confidence interval [CI], 15-40%), in-hospital mortality rate by 10% (95% CI, 5-15%), and absolute reduction in length of stay by 4.57 days (95% CI, 2.30-6.38 d). [1] In another review, greater improvement in respiratory acidosis, hypercapnia, and tachypnea was noted after 1 hour on noninvasive ventilation, along with fewer complications related to intubation. [2] Experience in a case-control study suggests a reduction in nosocomial pneumonia from 22% to 8%, with fewer days in the ICU and lower mortality (26% down to >4%) in those treated with noninvasive ventilation as opposed to those who received endotracheal intubation. 3, 4 In case of our study NIV trial in Acute exacerbation of COPD was 100% successful (6 out of 6). In our study Acute cardiogenic pulmonary oedema has over all success rata 15 out of 21( 71.42%), but thouse who had ongoing ischemia (relative contraindication) had increased failure rate (only 2 succeded out of 6). But those pts who did not have active ischemia has a better outcome (13 out of 15).
Noninvasive Ventilation After Extubation
A systematic review and meta-analyses of noninvasive ventilation and weaning in slightly more than 500 patients (mostly COPD patients) found that the use of noninvasive ventilation reduced mortality rates by 45% (RR, 0.55; 95% CI, 0.38-0.79), ventilator-associated pneumonia rates by 71% (RR, 0.29; 95% CI, 0.19-0.45), weighted duration of ICU stay by 6.27 days (95% CI, 8.77-3.78 d), and hospital days by 7.19 days (10.8-3.58 d) compared with a conventional weaning approach. The duration of endotracheal intubation was reduced by 7.81 days (95% CI, 11.3-4.31 d), as was the need for tracheostomy. However, reintubation rates were not decreased. 6 Post Extubation: So far our success rate was 100% (3 out of 3). Do-not-intubate status (advanced disease or terminal malignancy) 7 Benefit in dyspnea relief for patients with terminal malignancy 8 Although NIV trial in these patients had 100% failure rate but this method may be applied to relieve acute respiratory distress for some time.
Conclusion:
